Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.27 | N/A |
| PEG Ratio (TTM) | 1.72 | N/A |
| P/S Ratio (TTM) | 2.53 | N/A |
| P/B Ratio (TTM) | 1.17 | N/A |
| P/FCF Ratio (TTM) | 157.76 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.97 | N/A |
| Price to 5YR AVG FCF Ratio | 8.84 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.82% | N/A |
| ROE (TTM) | 9.20% | N/A |
| Net Profit Margin (TTM) | 18.97% | N/A |
| ROIC 5YR AVG | 12.31% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.83% | 10.73% | -1.21% |
| Revenue | -3.79% | 5.66% | 1.04% |
| Net Income | 10.63% | 9.27% | -2.51% |
| Cash Flow | -20.94% | 196.47% | 105.46% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.25 | N/A |
| Quick Ratio (TTM) | 1.25 | N/A |
| D/E Ratio (TTM) | 1.06 | N/A |
| Interest Coverage (TTM) | 0.52 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.36 | N/A |
| LTL to 5YR AVG FCF | 0.63 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.33% | N/A |